Fundamentals - AlphaKey Financial

Stock Fundamentals

Company Information

▼

Company Name

Dianthus Therapeutics Inc.

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ISIN: US2528281080

CIK: 0001690585

CUSIP: 252828108

Currency: USD

Full Time Employees: 92

Phone: 929 999 4055

Website: https://dianthustx.com

Fiscal Year End: December

IPO Date: Sep 12, 2023

Description:

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.

Address:

7 Times Square, New York, NY, United States, 10036

Directors & Officers

▼

Name	Title	Year Born
Mr. Marino Garcia M.B.A.	President, CEO & Director	1966
Mr. Ryan Savitz	Chief Financial Officer & Chief Business Officer	1989
Mr. Simrat Randhawa M.B.A., M.D.	Executive VP and Head of R&D	1970
Mr. Edward G. Carr	Chief Accounting Officer	1969
Mr. Judson Taylor	Senior VP & Head of Technical Operations	NA
Ms. Jennifer Davis Ruff	VP and Head of Investor Relations & Corporate Affairs	NA
Mr. Adam M. Veness Esq.	Senior VP, General Counsel & Secretary	1986
Ms. Kristina Maximenko	Chief People Officer	NA
Ms. Rashieda Gluck	Head of Clinical Development Operations	NA
Mr. Scott Nogi M.B.A.	Head of Business Operations	NA

Shares Statistics

▼

Shares Outstanding: 43.22M

Shares Float: 39.07M

% Insiders: 324.10%

% Institutions: 11,675.00%

Short % Float: 21.14%

Valuation Metrics

▼

Enterprise Value: $3.07B

Trailing P/E: 0.00

Forward P/E: 0.00

Financial Highlights

▼

Market Cap: $3.47B

EBITDA: $-177.82M

Book Value: $11.42

Earnings/Share: $-3.50

Profit Margin: 0.00%

Operating Margin: -24,486.27%

ROA (TTM): -24.58%

ROE (TTM): -38.38%

Revenue (TTM): $2.04M

Revenue/Share (TTM): $0.05

Earnings Growth (YOY): 0.00%

Revenue Growth (YOY): -78.60%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

Earnings History

▼

Date	EPS Actual	EPS Estimate	Difference	Surprise %
Dec 31, 2025	-1.43	-1.03	N/A	-3,864.65%
Sep 30, 2025	-0.97	-0.55	N/A	-7,636.36%
Jun 30, 2025	-0.88	-0.53	N/A	-6,603.77%
Mar 31, 2025	-0.82	-0.71	N/A	-1,549.30%
Dec 31, 2024	-0.81	-0.76	N/A	-657.89%
Sep 30, 2024	-0.72	-0.59	N/A	-2,203.39%
Jun 30, 2024	-0.51	-0.55	N/A	727.27%
Mar 31, 2024	-0.54	-0.44	N/A	-2,272.73%
Dec 31, 2023	-0.71	-1.01	N/A	2,970.30%
Sep 30, 2023	-3.78	-0.56	N/A	-57,500.00%
Jun 30, 2023	-0.87	-3.04	N/A	7,150.33%
Mar 31, 2023	-0.47	-0.40	N/A	-1,750.00%
Dec 31, 2022	-0.30	-0.28	N/A	-861.69%
Sep 30, 2022	-0.27	-0.29	N/A	689.66%
Jun 30, 2022	-0.29	-0.34	N/A	1,470.59%
Mar 31, 2022	-0.39	-0.32	N/A	-2,260.30%
Dec 31, 2021	-0.33	-0.32	N/A	-413.38%
Sep 30, 2021	-0.30	-0.33	N/A	867.58%
Jun 30, 2021	-0.32	-0.37	N/A	1,409.40%
Mar 31, 2021	-0.36	-0.39	N/A	721.65%
Dec 31, 2020	-0.38	-0.39	N/A	206.19%
Sep 30, 2020	-0.37	-0.43	N/A	1,395.35%
Jun 30, 2020	-0.48	-0.54	N/A	1,111.11%
Mar 31, 2020	-0.51	-0.60	N/A	1,500.00%
Dec 31, 2019	-0.59	-0.58	N/A	-172.41%
Sep 30, 2019	-0.54	-0.53	N/A	-188.68%
Jun 30, 2019	-0.48	-0.49	N/A	204.08%
Mar 31, 2019	-0.44	-0.55	N/A	2,000.00%
Dec 31, 2018	-0.50	-0.53	N/A	566.04%
Sep 30, 2018	-0.49	-0.67	N/A	2,686.57%
Jun 30, 2018	-3.13	-1.13	N/A	-17,699.12%
Mar 31, 2018	-4.45	0.00	N/A	N/A
Dec 31, 2017	-1.03	0.00	N/A	N/A
Mar 31, 2017	-0.15	0.00	N/A	N/A

Balance Sheet (Yearly)

▼

Date	Cash	Total Debt	Total Assets	Total Liabilities	Total Equity
2025-12-31	$51.09M	$N/A	$530.92M	$37.52M	$493.40M
2024-12-31	$22.79M	$N/A	$374.01M	$21.53M	$352.48M
2023-12-31	$132.33M	$N/A	$179.41M	$10.54M	$168.87M
2022-12-31	$15.37M	$N/A	$83.11M	$9.45M	$73.66M
2021-12-31	$131.65M	$N/A	$189.93M	$17.26M	$172.67M
2020-12-31	$58.15M	$N/A	$161.62M	$17.71M	$143.91M
2019-12-31	$65.07M	$N/A	$161.51M	$20.32M	$141.19M
2018-12-31	$58.35M	$N/A	$157.31M	$11.67M	$145.65M
2017-12-31	$51.57M	$N/A	$54.46M	$4.14M	$50.32M
2016-12-31	$4.54M	$N/A	$11.34M	$2.30M	$9.04M

Financial Ratios

▼

Date	Current Ratio	Debt/Equity	Debt/Assets	Interest Coverage	Debt/EBITDA
2025-12-31	13.32x	0.00x	0.07x	N/A	0.00x
2024-12-31	15.22x	0.00x	0.06x	N/A	0.00x
2023-12-31	18.42x	0.00x	0.06x	N/A	-0.01x
2022-12-31	9.97x	0.00x	0.11x	N/A	-0.01x
2021-12-31	16.63x	0.00x	0.09x	-3.68x	0.00x
2020-12-31	13.26x	0.00x	0.11x	-20.90x	0.00x
2019-12-31	10.62x	0.00x	0.13x	N/A	0.00x
2018-12-31	13.95x	0.00x	0.07x	N/A	0.00x
2017-12-31	12.68x	0.00x	0.08x	N/A	0.00x
2016-12-31	4.71x	0.00x	0.20x	-56.86x	0.00x

Insider Trading

Date	Insider Name	Title	Transaction Type	Shares	Price	Value
Dec 04, 2025	Ryan Savitz	N/A	Sale	20.00K	$45.18	$903.60K
Nov 14, 2025	Simrat Randhawa	N/A	Sale	109.03K	$38.14	$4.16M
Nov 13, 2025	Simrat Randhawa	N/A	Sale	87.51K	$36.81	$3.22M
Sep 09, 2025	Ryan Savitz	N/A	Sale	20.00K	$35.00	$700.00K

📦 Raw API Data (JSON Explorer)

▼

Comprehensive raw data returned from the EOD Fundamentals API. Expand sections below to drill down.

Stock Fundamentals

Company Information

Directors & Officers

Shares Statistics

Valuation Metrics

Financial Highlights

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Insider Trading

📦 Raw API Data (JSON Explorer)

Watchlist

Assistant